News tagged with dacarbazine
ASCO: Trametinib improves survival in metastatic melanoma
(HealthDay) -- For patients with metastatic melanoma with activating mutations in serine-threonine protein kinase B-RAF (BRAF), treatment with the oral selective MEK inhibitor trametinib is associated with ...
Cancer
Jun 05, 2012 |
not rated yet |
0
HIV status doesn't influence Hodgkin's lymphoma outcome
(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, ...
Cancer
Oct 11, 2012 |
not rated yet |
0
New melanoma drug may extend survival
(HealthDay) -- New research suggests that a new drug does a better job of combating advanced skin cancer in melanoma patients than chemotherapy.
Cancer
Jun 25, 2012 |
not rated yet |
0
|
Cancer drug improves survival in patients with metastatic melanoma
(Medical Xpress)—Results of a University of Arizona Cancer Center's scientist-led clinical trial show that a drug already approved for breast and lung cancer improved progression-free survival in patients ...
Cancer
Nov 14, 2012 |
5 / 5 (2) |
0
|
Indication of considerable added benefit of vemurafenib in advanced melanoma
Vemurafenib has been approved since February 2012 for the treatment of certain groups of adults with advanced melanoma. The drug offers major advantages in terms of survival, but also causes major side effects. Overall, there ...
Cancer
Jan 08, 2013 |
not rated yet |
0
